The S.E.C. alleged shortcomings in research said to support the drug, and its developer agreed to a $40 million settlement.

Variations in the use of antidementia and antipsychotic drugs for nursing home residents with dementia across the United ...

Dementia is the biggest health challenge facing the UK’s ageing population with 900,000 currently living with the disease and predicted to increase to 1.6 million by 2050. Now, for the first time, a ...

In people with Alzheimer's disease, they clump together, starve brain cells of nutrients and slow down signals in the organ ...

An international team of researchers have made a promising breakthrough in the development of drugs to treat Alzheimer’s ...

Dementia therapies may help relieve symptoms, but many different options are available. Some may help more than others.

RESEARCHERS have developed a drug that successfully blocks two major Alzheimer’s disease “hotspots” at once, in a “promising” breakthrough against the brain robbing ...

Monash University researchers are assessing a new drug that could be a game changer for the dementia that has struck US actor Bruce Willis, and ...

The rate of antipsychotic drug use in nursing homes has remained stubbornly high. Experts are concerned about misuse.

The use of SGLT2 inhibitors vs DDP-4 inhibitors is associated with a reduced risk of developing different types of dementia.

SGLT2 inhibitors, a class of diabetes drugs, may reduce the risk of Alzheimer’s, vascular dementia, and Parkinson’s disease, ...

Scientists have developed a drug that targets both major aggregation-promoting sites of the Tau protein, a key player in ...